EVALUATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY INVIVO IN PATIENTS TREATED WITH HIGH-DOSE INTERLEUKIN-2 AND ADOPTIVE TRANSFER OF AUTOLOGOUS LAK CELLS

被引：17
|
作者：
WALEWSKI, J
PAIETTA, E
DUTCHER, J
WIERNIK, PH
机构：
[1] MONTEFIORE MED CTR,DEPT ONCOL,111 E 210TH ST,BRONX,NY 10467
[2] ALBERT EINSTEIN MED CTR,DEPT MED,BRONX,NY 10467
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1989年 / 115卷 / 02期
关键词：
D O I：
10.1007/BF00397919
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 174
页数：5
相关论文
共 50 条
  • [41] LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY IN A SPONTANEOUSLY DEVELOPED SYNGENEIC MURINE MAMMARY-TUMOR
    CHAO, TY
    AUNGST, CW
    CHU, TM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 403 - 403
  • [42] INTERLEUKIN-2 AUGMENTS NATURAL-KILLER CELL-ACTIVITY
    HENNEY, CS
    KURIBAYASHI, K
    KERN, DE
    GILLIS, S
    NATURE, 1981, 291 (5813) : 335 - 338
  • [43] IMMUNOTHERAPY OF CANCER USING LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND INTERLEUKIN-2 (IL 2)
    ROSENBERG, SA
    ETTINGHAUSEN, SE
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 59 - 59
  • [44] DEMONSTRATION OF CIRCULATING LYMPHOKINE ACTIVATED KILLER (LAK) CELLS IN PATIENTS RECEIVING INTERLEUKIN-2 (IL-2)
    MCMANNIS, JD
    BRAUN, DP
    FISHER, RI
    CREEKMORE, SP
    HARRIS, JE
    ELLIS, TM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 372 - 372
  • [45] LYMPHOKINE-ACTIVATED KILLERS (LAK) VS NATURAL-KILLER (NK) CELLS AND CYTOTOXIC LYMPHOCYTES-T (CTL)
    BALLAS, ZK
    MARSHALL, GD
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 488 - 488
  • [46] THYROID FUNCTIONS IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    KUNG, AWC
    LAI, CL
    WONG, KL
    TAM, CF
    QUARTERLY JOURNAL OF MEDICINE, 1992, 82 (297): : 33 - 42
  • [47] EXPRESSION OF IL-10 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY IN INFLAMMATORY BOWEL-DISEASE
    SHINODA, M
    KUSUGAMI, K
    HARUTA, J
    TANIMOTO, M
    ANDO, T
    INA, K
    KUROIWA, A
    SAITO, Y
    MATSUURA, T
    YAMAGUCHI, T
    HOSOKAWA, T
    MORISE, K
    IEDA, M
    IOKAWA, H
    ISHIHARA, A
    SARAI, S
    GASTROENTEROLOGY, 1994, 106 (04) : A773 - A773
  • [48] LYMPHOKINE-ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY
    EGGERMONT, AMM
    SUGARBAKER, PH
    CELLULAR IMMUNOLOGY, 1987, 107 (02) : 384 - 394
  • [49] LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY IN B-CHRONIC AND T-CHRONIC LYMPHOID LEUKEMIA - DEFECTIVE LAK GENERATION AND REDUCED SUSCEPTIBILITY OF THE LEUKEMIC-CELLS TO ALLOGENEIC AND AUTOLOGOUS LAK EFFECTORS
    FOA, R
    FIERRO, MT
    RASPADORI, D
    BONFERRONI, M
    CARDONA, S
    GUARINI, A
    TOS, AG
    DICELLE, PF
    CESANO, A
    MATERA, L
    LAURIA, F
    GAVOSTO, F
    BLOOD, 1990, 76 (07) : 1349 - 1354
  • [50] SEVERE HYPOVITAMINOSIS-C OCCURRING AS THE RESULT OF ADOPTIVE IMMUNOTHERAPY WITH HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    MARCUS, SL
    DUTCHER, JP
    PAIETTA, E
    CIOBANU, N
    STRAUMAN, J
    WIERNIK, PH
    HUTNER, SH
    FRANK, O
    BAKER, H
    CANCER RESEARCH, 1987, 47 (15) : 4028 - 4212
12345